134 related articles for article (PubMed ID: 37890928)
1. Pipeline to characterize antigen-specific TCR repertoires in tumors: Examples from an HPV16 tumor model.
Rudqvist NP
Methods Cell Biol; 2023; 180():15-24. PubMed ID: 37890928
[TBL] [Abstract][Full Text] [Related]
2. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
4. TCR Repertoire Analysis Reveals Mobilization of Novel CD8
Aoki H; Ueha S; Shichino S; Ogiwara H; Hashimoto SI; Kakimi K; Ito S; Matsushima K
Front Immunol; 2018; 9():3185. PubMed ID: 30733724
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
Schrama D; Ritter C; Becker JC
Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
[TBL] [Abstract][Full Text] [Related]
6. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
Front Immunol; 2020; 11():587014. PubMed ID: 33163002
[TBL] [Abstract][Full Text] [Related]
8. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
Aoki H; Shichino S; Matsushima K; Ueha S
Front Immunol; 2022; 13():807696. PubMed ID: 35154125
[TBL] [Abstract][Full Text] [Related]
9. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
Zhu X; Zhu P; Guo XL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
Li N; Yuan J; Tian W; Meng L; Liu Y
Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
[TBL] [Abstract][Full Text] [Related]
12. [T cell receptor-based immunotherapy: a review].
Chen Y; Gao GF; Tan S
Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4004-4028. PubMed ID: 37877387
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Distinct T Cell Receptor Repertoires in Tumor and Distant Non-tumor Tissues from Lung Cancer Patients.
Wang X; Zhang B; Yang Y; Zhu J; Cheng S; Mao Y; Feng L; Xiao T
Genomics Proteomics Bioinformatics; 2019 Jun; 17(3):287-296. PubMed ID: 31479759
[TBL] [Abstract][Full Text] [Related]
14. TCR repertoires of intratumoral T-cell subsets.
Linnemann C; Mezzadra R; Schumacher TN
Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive investigation of T and B cell receptor repertoires in an MC38 tumor model following murine anti‑PD‑1 administration.
Zhang L; Wang IM; Solban N; Cristescu R; Zeng G; Long B
Mol Med Rep; 2020 Aug; 22(2):975-985. PubMed ID: 32468004
[TBL] [Abstract][Full Text] [Related]
16. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
[TBL] [Abstract][Full Text] [Related]
17. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
[TBL] [Abstract][Full Text] [Related]
19. The splenic T cell receptor repertoire during an immune response against a complex antigen: Expanding private clones accumulate in the high and low copy number region.
Meinhardt M; Tune C; Schierloh LK; Schampel A; Pagel R; Westermann J
PLoS One; 2022; 17(8):e0273264. PubMed ID: 36001559
[TBL] [Abstract][Full Text] [Related]
20. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
Genolet R; Bobisse S; Chiffelle J; Arnaud M; Petremand R; Queiroz L; Michel A; Reichenbach P; Cesbron J; Auger A; Baumgaertner P; Guillaume P; Schmidt J; Irving M; Kandalaft LE; Speiser DE; Coukos G; Harari A
Cell Rep Methods; 2023 Apr; 3(4):100459. PubMed ID: 37159666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
